Inflammatory Response Modulation by Vitamin C in an MPTP Mouse Model of Parkinson's Disease.

Parkinson’s disease inflammasome neuroinflammation neuroprotection vitamin C

Journal

Biology
ISSN: 2079-7737
Titre abrégé: Biology (Basel)
Pays: Switzerland
ID NLM: 101587988

Informations de publication

Date de publication:
09 Nov 2021
Historique:
received: 19 10 2021
revised: 02 11 2021
accepted: 04 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 28 11 2021
Statut: epublish

Résumé

Vitamin C (Vit C) is anutrient present in many foods, particularly citrus fruits, green vegetables, tomatoes, and potatoes. Vit C is studied for its applications in the prevention and management of different pathologies, including neurodegenerative diseases. Neuroinflammation is a defense mechanism activated by a stimulus or an insult that is aimed at the preservation of the brain by promoting tissue repair and removing cellular debris; however, persistent inflammatory responses are detrimental and may lead to the pathogenesis and progression of neurodegenerative diseases like Parkinson's disease (PD) and Alzheimer's disease. PD is one of the most common chronic progressive neurodegenerative disorders, and oxidative stress is one of the most important factors involved in its pathogenesis and progression.Due to this, research on antioxidant and anti-inflammatory compounds is an important target for counteracting neurodegenerative diseases, including PD. In the central nervous system, the presence of Vit C in the brain is higher than in other body districts, but why and how this occurs is still unknown. In this research, Vit C, with its anti-inflammatory and anti-oxidative properties, is studied to better understand its contribution to brain protection; in particular, we have investigated the neuroprotective effects of Vit C in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced animal model of PD and its role in the modulation of neuroinflammation. First, we observed that Vit C significantly decreased the MPTP-induced loss of tyrosine hydroxylase (TH)-positive dopaminergic neuronal cells in the substantia nigra, as well as microglial cell activation and astrogliosis. Furthermore, gait and spontaneous locomotor activity, evaluated by an automated treadmill and the Open Field test, respectively, were partially ameliorated by Vit C treatment in MPTP-intoxicated animals. In relation to neuroinflammation, results show that Vit C reduced the protein and mRNA expression of inflammatory cytokines such as IL-6, TLR4, TNF-α, iNOS, and CD40, while anti-inflammatory proteins such as IL-10, CD163, TGF-β, and IL-4 increased. Interestingly, we show for the first time that Vit C reduces neuroinflammation by modulating microglial polarization and astrocyte activation. Moreover, Vit C was able to reduce NLRP3 activation, which is linked to the pathogenesis of many inflammatory diseases, including neuroinflammatory disorders. In conclusion, our study provides evidence that Vit C may represent a new promising dietary supplement for the prevention and alleviation of the inflammatory cascade of PD, thus contributing to neuroprotection.

Identifiants

pubmed: 34827148
pii: biology10111155
doi: 10.3390/biology10111155
pmc: PMC8614932
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Nature. 2013 Jan 31;493(7434):674-8
pubmed: 23254930
Nutrients. 2021 Apr 23;13(5):
pubmed: 33922475
Neurosci Bull. 2018 Apr;34(2):270-282
pubmed: 29124672
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a008870
pubmed: 22675666
Adv Nutr. 2011 Mar;2(2):78-88
pubmed: 22332036
J Cereb Blood Flow Metab. 2014 Apr;34(4):660-7
pubmed: 24424382
Crit Care. 2017 Dec 11;21(1):300
pubmed: 29228951
Curr Genomics. 2011 Aug;12(5):371-8
pubmed: 22294879
Can J Physiol Pharmacol. 1997 Oct-Nov;75(10-11):1149-63
pubmed: 9431439
Front Cell Neurosci. 2017 May 26;11:154
pubmed: 28603491
FEBS Lett. 1999 Nov 5;460(3):480-4
pubmed: 10556521
Brain Behav. 2020 Jun;10(6):e01636
pubmed: 32333523
J Neuroinflammation. 2017 Dec 20;14(1):256
pubmed: 29262843
Q J Exp Physiol. 1986 Jul;71(3):483-9
pubmed: 3763810
Science. 2009 Sep 11;325(5946):1405-8
pubmed: 19745156
Nat Protoc. 2007;2(1):141-51
pubmed: 17401348
Oxid Med Cell Longev. 2021 Jan 19;2021:6679708
pubmed: 33542783
Glia. 2013 May;61(5):813-24
pubmed: 23404620
Nature. 1999 May 6;399(6731):70-5
pubmed: 10331392
Neurosci Bull. 2010 Feb;26(1):66-76
pubmed: 20101274
Front Neurosci. 2020 Oct 19;14:567129
pubmed: 33192254
Parkinsonism Relat Disord. 2015 Aug;21(8):877-81
pubmed: 26037459
J Neuroinflammation. 2008 Feb 27;5:8
pubmed: 18304357
J Immunol Res. 2016;2016:9238290
pubmed: 27652274
Behav Brain Res. 2019 Jan 1;356:483-489
pubmed: 29885849
Stroke. 2012 Nov;43(11):3063-70
pubmed: 22933588
Trends Immunol. 2011 Aug;32(8):373-9
pubmed: 21733753
Curr Pharm Des. 2012;18(2):200-8
pubmed: 22229581
Antioxidants (Basel). 2021 May 18;10(5):
pubmed: 34069836
Immunopharmacology. 1998 Jun;39(3):167-80
pubmed: 9754903
Cell. 2015 Jan 15;160(1-2):62-73
pubmed: 25594175
J Neurochem. 2006 Jun;97(6):1634-58
pubmed: 16805774
Pharmacol Ther. 2018 Sep;189:63-70
pubmed: 29684467
J Neuroeng Rehabil. 2005 Jul 25;2:20
pubmed: 16042805
J Am Coll Nutr. 2003 Feb;22(1):18-35
pubmed: 12569111
Curr Top Membr. 2012;70:357-75
pubmed: 23177992
Phytother Res. 2019 Mar;33(3):756-767
pubmed: 30637814
Glia. 2005 Apr 1;50(1):32-47
pubmed: 15625716
J Immunol. 2009 Jul 15;183(2):787-91
pubmed: 19570822
J Neurosci. 2016 Oct 26;36(43):10990-11005
pubmed: 27798180
J Parkinsons Dis. 2013;3(4):461-91
pubmed: 24252804
Int J Mol Sci. 2021 Apr 28;22(9):
pubmed: 33925154
Neuroscientist. 2021 Feb 13;:1073858421992265
pubmed: 33586516
Prog Neurobiol. 2017 Aug;155:57-75
pubmed: 27107797
Nature. 2001 Dec 20-27;414(6866):920-4
pubmed: 11780066
Int Immunopharmacol. 2019 Jun;71:328-335
pubmed: 30952097
J Stem Cell Res Ther. 2014 May 19;4(5):209
pubmed: 25110615

Auteurs

Francesco De Nuccio (F)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, I-73100 Lecce, Italy.

Antonia Cianciulli (A)

Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, I-70125 Bari, Italy.

Chiara Porro (C)

Department of Clinical and Experimental Medicine, University of Foggia, I-71100 Foggia, Italy.

Marianna Kashyrina (M)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, I-73100 Lecce, Italy.

Melania Ruggiero (M)

Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, I-70125 Bari, Italy.

Rosa Calvello (R)

Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, I-70125 Bari, Italy.

Alessandro Miraglia (A)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, I-73100 Lecce, Italy.

Giuseppe Nicolardi (G)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, I-73100 Lecce, Italy.

Dario Domenico Lofrumento (DD)

Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, I-73100 Lecce, Italy.

Maria Antonietta Panaro (MA)

Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, I-70125 Bari, Italy.

Classifications MeSH